CPT Pharmacometrics Syst Pharmacol
CPT Pharmacometrics Syst Pharmacol
Country: Unknown
Publisher: Unknown
Publication Period: Unknown
572
Papers in Database
Journal Information
Publication Details
Additional Information
Subject Term Count: 1
Last Updated: Aug 05, 2025
Recent Papers
View All 572 PapersAdult and pediatric physiologically-based biopharmaceutics modeling to explain lamotrigine immediate release absorption…
Caleffi-Marchesini ER, Herling AA, Macente J, Bonan RH, de Freitas Lima P, Moreno R, Alexandre V, C…
A Markov model of fibrosis development in nonalcoholic fatty liver disease predicts fibrosis progression in clinical co…
Knöchel J, Bergenholm L, Ibrahim E, Kechagias S, Hansson S, Liljeblad M, Nasr P, Carlsson B, Eksted…
A mechanistic modeling platform of SGLT2 inhibition: Implications for type 1 diabetes.
Sokolov V, Yakovleva T, Stolbov L, Penland RC, Boulton D, Parkinson J, Tang W.
A "middle-out approach" for the prediction of human drug disposition from preclinical data using simplified physiologic…
Yau E, Gertz M, Ogungbenro K, Aarons L, Olivares-Morales A.
A model-based approach leveraging in vitro data to support dose selection from the outset: A framework for bispecific a…
Sánchez J, Claus C, Albrecht R, Gaillard BC, Marinho J, McIntyre C, Tanos T, Boehnke A, Friberg LE,…
A model-based meta analysis study of sodium glucose co-transporter-2 inhibitors.
Yao X, Zhou J, Song L, Ren Y, Hu P, Liu D.
A physiologically-based pharmacokinetic model for tuberculosis drug disposition at extrapulmonary sites.
Ramachandran A, Gadgil CJ.
Apixaban and rivaroxaban's physiologically-based pharmacokinetic model validation in hospitalized patients: A first ste…
Terrier J, Gaspar F, Gosselin P, Raboud O, Lenoir C, Rollason V, Csajka C, Samer C, Fontana P, Daal…
A prognostic baseline blood biomarker and tumor growth kinetics integrated model in paclitaxel/platinum treated advance…
Ojara FW, Henrich A, Frances N, Nassar YM, Huisinga W, Hartung N, Geiger K, Holdenrieder S, Joerger…
Assessment of CYP3A-mediated drug interaction via cytokine (IL-6) elevation for mosunetuzumab using physiologically-bas…
Chen Y, Ma F, Jones N, Deng R, Li C, Li CC.